{
  "id": "CritAssess286",
  "type": "CriterionAssessment",
  "criterion": {
    "id": "Crit306",
    "type": "Criterion",
    "label": "PS3",
    "description": "Well-established in vitro or in vivo functional studies supportive of a damaging effect on the gene or gene product",
    "defaultStrength": {
      "id": "ELSID145",
      "type": "EvidenceLineStrength",
      "label": "Pathogenic Strong"
    },
    "comments": "This particular rule will probably be downgraded often, given that there are not many “Functional studies that have been validated and shown to be reproducible and robust in a clinical diagnostic laboratory setting”"
  },
  "variant": {
    "id": "CanAll020",
    "type": "CanonicalAllele",
    "preferredCtxAllele": {
      "id": "CtxAll023",
      "type": "ContextualAllele",
      "relatedCanonicalAllele": "CanAll020",
      "alleleName": "NM_004333.4(BRAF):c.1787G>T",
      "produces": [
        {
          "id": "CtxAll024",
          "type": "ContextualAllele",
          "relatedCanonicalAllele": "CanAll021",
          "alleleName": "NP_004324.2:p.Gly596Val",
          "producedBy": "CtxAll023"
        }
      ]
    }
  },
  "outcome": {
    "id": "CEID074",
    "type": "CriterionEvaluation",
    "label": "Met"
  },
  "evidenceLine": [
    {
      "id": "EvLn017",
      "type": "EvidenceLine",
      "evidenceItem": [
        {
          "id": "Func026",
          "type": "AlleleFunctionalImpact",
          "resultDescription": "abnormal/deceased MEK activtation.",
          "assayType": {
            "id": "AFITID076",
            "type": "AlleleFunctionalImpactType",
            "label": "Activation Assay"
          },
          "contextualAllele": {
            "id": "CtxAll024",
            "type": "ContextualAllele",
            "relatedCanonicalAllele": "CanAll021",
            "alleleName": "NP_004324.2:p.Gly596Val",
            "producedBy": "CtxAll023"
          },
          "gene": {
            "id": "G240",
            "type": "Gene",
            "geneSymbol": "MEK"
          }
        }
      ]
    },
    {
      "id": "EvLn018",
      "type": "EvidenceLine",
      "evidenceItem": [
        {
          "id": "Func027",
          "type": "AlleleFunctionalImpact",
          "resultDescription": "abnormal/deceased ERK activtation.",
          "assayType": {
            "id": "AFITID076",
            "type": "AlleleFunctionalImpactType",
            "label": "Activation Assay"
          },
          "contextualAllele": {
            "id": "CtxAll024",
            "type": "ContextualAllele",
            "relatedCanonicalAllele": "CanAll021",
            "alleleName": "NP_004324.2:p.Gly596Val",
            "producedBy": "CtxAll023"
          },
          "gene": {
            "id": "G241",
            "type": "Gene",
            "geneSymbol": "ERK"
          }
        }
      ]
    }
  ],
  "contribution": [
    {
      "type": "Contribution",
      "agent": {
        "id": "Agent001",
        "type": "Agent",
        "label": "Harry Stevenson"
      },
      "contributionDate": "6/4/16 7:12 AM",
      "contributionRole": {
        "id": "CRID193",
        "type": "ContributoryRole",
        "label": "assessor role"
      }
    },
    {
      "type": "Contribution",
      "agent": {
        "id": "Agent002",
        "type": "Agent",
        "label": "Noonan/Rasopathy WG (ClinGen)"
      },
      "contributionDate": "6/4/16 7:12 AM",
      "contributionRole": {
        "id": "CRID193",
        "type": "ContributoryRole",
        "label": "assessor role"
      }
    }
  ],
  "description": "The RASopathy group considers MEK and ERK activation assays as well validated."
}
